Browse by Uncontrolled Keywords
Number of items: 7.
2012
Kotseva, K;
Jennings, CS;
Turner, EL;
Mead, A;
Connolly, S;
Jones, J;
Bowker, TJ;
Wood, DA;
Grp, A.-, PS;
(2012)
ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK.
Heart (British Cardiac Society), 98 (11).
pp. 865-871.
ISSN 1355-6037
DOI: https://doi.org/10.1136/heartjnl-2011-301603
Full text not available from this repository.
2010
Hann, A;
Peckham, S;
(2010)
Cholesterol screening and the Gold Effect.
Health, risk & society, 12 (1).
pp. 33-50.
ISSN 1369-8575
DOI: https://doi.org/10.1080/13698570903499608
Full text not available from this repository.
Pocock, SJ;
Mehran, R;
Clayton, TC;
Nikolsky, E;
Parise, H;
Fahy, M;
Lansky, AJ;
Bertrand, ME;
Lincoff, AM;
Moses, JW;
+3 more...
Ohman, EM;
White, HD;
Stone, GW;
(2010)
Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications Assessment From the Acute Catheterization and Urgent Intervention Triage Strategy Trial.
Circulation, 121 (1).
pp. 43-51.
ISSN 0009-7322
DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.878017
Full text not available from this repository.
Wordsworth, S;
Leal, J;
Blair, E;
Legood, R;
Thomson, K;
Seller, A;
Taylor, J;
Watkins, H;
(2010)
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
European heart journal, 31 (8).
pp. 926-935.
ISSN 0195-668X
DOI: https://doi.org/10.1093/eurheartj/ehq067
Full text not available from this repository.
2006
Knopp, RH;
D'Emden, M;
Smilde, JG;
Pocock, SJ;
(2006)
Efficacy and safe of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes - The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN).
Diabetes care, 29 (7).
pp. 1478-1485.
ISSN 0149-5992
DOI: https://doi.org/10.2337/dc05-2415
Full text not available from this repository.
2005
Pocock, SJ;
(2005)
When (not) to stop a clinical trial for benefit.
JAMA, 294 (17).
pp. 2228-2230.
ISSN 0098-7484
DOI: https://doi.org/10.1001/jama.294.17.2228
2003
Wang, DL;
Lertsithichai, P;
Nanchahal, K;
Yousufuddin, M;
(2003)
Risk factors of coronary heart disease: a Bayesian model averaging approach.
Journal of applied statistics, 30 (7).
pp. 813-826.
ISSN 0266-4763
DOI: https://doi.org/10.1080/0266476032000076074
Full text not available from this repository.